Part 1    |    Part 2    |    Part 3

 

 

 

Cancer Research Series Part 3 | September 29th, 7pm-8pm ET

Cancer Research and You: Real-World Stories from Research Participants

Cancer research exists to save lives, improve the quality of life for the cancer community, and change healthcare for the better. In this program, we will hear the perspective of cancer survivors like you that have participated in different types of cancer research.  There is more to cancer research than you think. Join us to hear the unfiltered stories of what it means to be a cancer research participant and how you can make healthcare care more about the cancer community and influence real change. 

Speakers

  • Robert Matney, Melanoma Cancer Survivor
  • Jennifer Brouwer, Breast Cancer Survivor
  • Melanie Croce-Galis, RN, MPH, Lymphoma Cancer Survivor
  • Jeff Guffey, MAEd, Melanoma and Thyroid Cancer Survivor

 

Robert Matney, Melanoma Cancer Survivor

When Robert was diagnosed with stage III melanoma, he needed to quickly determine what treatment he should pursue to manage his disease. The first step was to remove the area around the melanoma site and 39 lymph nodes. After his surgery, Robert turned his energy to finding a treatment to keep his cancer in remission. Through the help of his medical team at MD Anderson, he enrolled in a clinical trial in Virginia.

Robert is currently living with no evidence of disease (NED). While he will never know if the clinical trial deserves credit for his NED, he knows he tried his best by pursuing the treatment that was best for him; a clinical trial.

See more of Robert's writing here:

 

Jennifer Brouwer, Breast Cancer Survivor

In 2020, Jennifer was diagnosed with stage II triple positive breast cancer. She has gone through radiation, chemotherapy, and several surgeries. Through that process, she has become an advocate, advocating the importance of listening to your body and open communication with your medical team. She is currently in a clinical trial for HER2 Positive patients. Jennifer has two children and enjoys kayaking, hiking, and working out.

 

Melanie Croce-Galis, RN, MPH, Lymphoma Cancer Survivor

In the wake of her lymphoma diagnosis in 2004, Melanie quickly learned that sharing her story had the power to help others. Melanie became an advocate, sharing her story of survival to provide hope and help others learn from her experiences. She has participated in numerous patient experience research initiatives as a patient herself and as a parent of a child with a rare genetic disorder.

 

Jeff Guffey, MAEd, Melanoma and Thyroid Cancer Survivor

At the age of 35, Jeff was diagnosed with melanoma. Since his initial diagnosis he has been diagnosed with thyroid cancer, had two recurrences of thyroid cancer and two recurrences of melanoma. Jeff currently receives treatment at the North Carolina Cancer Hospital for stage IV melanoma.

Prior to his diagnosis, Jeff studied exercise science, graduating with an undergraduate in exercise and sport science, with concentrations in science education and sports medicine. He continued his education at East Carolina earning a Master’s Degree in science education. Jeff spent 15 years teaching high school and working as the head athletic trainer. He was also a volunteer firefighter for 23 years.

In his spare time he enjoys playing bass guitar in the worship team at his church and spending time with his dog, Noma. He enjoys traveling and is planning some big adventures with Noma coming up. He enjoys helping individuals who are newly diagnosed with cancer and those going through treatment.

 

 

 

Cancer Research Series Part 2 | August 25th, 7pm-8pm ET

Cancer Research and You: Your Experience Empowers Change

Read our blog post recap of this program here!

Cancer research can seem scary. Typically, people think of blood draws and a lab with beakers and microscopes. Did you know there is a different kind of cancer research? Patient experience research collects thoughts from patients, survivors, and caregivers. This qualitative data allows companies like GRYT Health to help shape the future of cancer care based on what you have to say! In this interactive session, you’ll hear from our Chief Research Officer, Dr. Darcy Flora, and our Chief Medical Officer, Dr. Dan Platt, about some of the most impactful projects we’ve done with our community. We’ll also dive into why it is important for you to not only learn about research, but participate as an advocate because your voice has the potential to change the future of cancer care.

Speakers

  • Darcy Flora, PhD, Chief Research Officer, GRYT Health
  • Dan Platt, MD, Chief Medical Officer, GRYT Health

 

Darcy Flora, PhD, Chief Research Officer, GRYT Health

Darcy Flora, PhD, is the chief research officer at GRYT Health. She holds a Doctor of Philosophy (PhD) degree in Pharmacology from the University of Minnesota Medical School. Darcy has more than 15 years of combined experience in molecular and clinical pharmacology and patient experience research. She is passionate about working with the cancer community to make research more understood and accessible, helping patients and caregivers use their voice to improve future care and resources and understand their impact, and connecting research participants to information and resources. Darcy lives in Colorado and enjoys exploring the outdoors with her two Labrador retrievers.

 

Dan Platt, MD, Chief Medical Officer, GRYT Health

Dan Platt, MD, is the chief medical officer at GRYT Health. He has spent the majority of his life engaged in making the healthcare system more responsive to the needs of patients. Dan holds a Doctor of Medicine (MD) degree with distinction in research from the University of Rochester School of Medicine and Dentistry. He recently moved back to Rochester after having spent the last 10 years in Boston as a resident in neurology and consultant to biotech, pharma, and industry. Dan has extensive experience in the immuno-oncology space, having also served as the Executive Director, Medical Strategy and Development, for Advaxis Immunotherapies. He is passionate about improving the prevention and treatment of cancer, educating and advocating for patients, and reshaping healthcare to be effective, efficient, and equitable.

 

 

 

Cancer Research Series Part 1 | July 29th, 12pm-1pm ET

Cancer Research and You: Understanding Clinical Trials

Read our blog post recap of this program here!

Wondering what clinical trials are all about and if they are right for you? Join us for the first part of GRYT Health’s Research Program Series, Cancer Research & You. We will be discussing clinical trials, their importance in advancing cancer care, how you can find clinical trials and common misconceptions about them. This will be an interactive and informative program with the opportunity to ask cancer research professionals from our partner, Ancora.ai and our own Dr. Dan, some of your biggest questions about clinical trials.

You can watch the recording of this program below:

 

Speakers

  • Emily Jordan, PhD, Ancora.ai
  • Dan Platt, MD, Chief Medical Officer, GRYT Health

 

Speaker Bios

Emily Jordan, PhD, Ancora.ai

Emily Jordan, PhD, is the COO and cofounder of Ancora.ai. Ancora.ai's mission is to empower every patient to understand and have access to clinical research, as well as to support them throughout the clinical trial journey. Emily has a PhD in neuroscience from the University of Cambridge, where she was a Gates Cambridge Scholar, and an undergraduate degree from Columbia. She has spent her career working at the intersection of science and tech, and has a passion for improving health equity. At Ancora.ai, Emily leads patient outreach and education, content creation and operations.

         

 

Dan Platt, MD, Chief Medical Officer, GRYT Health

Dan Platt, MD, is the chief medical officer at GRYT Health. He has spent the majority of his life engaged in making the healthcare system more responsive to the needs of patients. Dan holds a Doctor of Medicine (M.D.) degree with distinction in research from the University of Rochester School of Medicine and Dentistry. He recently moved back to Rochester after having spent the last 10 years in Boston as a resident in neurology and consultant to biotech, pharma, and industry. Dan has extensive experience in the immuno-oncology space, having also served as the Executive Director, Medical Strategy and Development, for Advaxis Immunotherapies. He is passionate about improving the prevention and treatment of cancer, educating and advocating for patients, and reshaping healthcare to be effective, efficient, and equitable.